Pien Huang

Pien Huang is a global health and development reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.

She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.

Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.

More than 500,000 people have died from COVID-19 in the U.S.

This week President Biden is asking Americans to mark the 500,000 deaths with a moment of silence at sunset Monday. He's also ordered flags on all federal buildings lowered to half-staff for five days.

The process to sign up for COVID-19 vaccines varies by place so NPR created a tool to help you understand how things work in your state and connect you with local resources.

COVID-19 vaccines are scarce. Many people who want the shots can't get them yet, either because they're not yet eligible, according to priorities set by their state or county, or because there aren't any available appointments.

This page is updated regularly.

The U.S. is working to vaccinate a high percentage of its population against COVID-19 as soon as possible to stop the spread of the disease and end the outbreak in the country.

The mission becomes even more urgent as coronavirus variants emerge around the world, raising concerns that the virus could evade our efforts to control it, if the spread is not curbed quickly.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

President Biden announced a plan today to boost the supply of COVID-19 vaccines. He says the government is buying 200 million more and that it's working with states to get them out efficiently. Here to talk about these plans is NPR's Pien Huang.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

One hundred million vaccine doses in 100 days - that is President Joe Biden's goal. Health experts say it sounds ambitious, but it is within reach. NPR's Pien Huang reports.

Each week, we answer "frequently asked questions" about life during the coronavirus crisis. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject line: "Weekly Coronavirus Questions."

Updated 5:06 p.m. ET

On Friday afternoon, President-Elect Joe Biden shared a detailed plan to tackle the COVID-19 vaccination rollout, promising to fight the pandemic with "the full strength of the federal government."

In a speech in Delaware, Biden laid out his five-part plan for how to speed up the vaccination campaign: Open up vaccine eligibility to more people; create more vaccination sites; increase vaccine supply; hire a vaccination workforce; and launch a large-scale public education campaign.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

RACHEL MARTIN, HOST:

Updated 2:20 p.m. ET

The Trump administration is making several big changes to its COVID-19 vaccine distribution strategy, officials announced Tuesday, in a bid to jump-start the rollout and get more Americans vaccinated quickly.

The first change is to call on states to expand immediately the pool of people eligible to receive vaccines to those 65 and older, and those with underlying health conditions that make them more susceptible to COVID-19.

This time last year, the world was heading into a pandemic that would upend everything and cost 1.9 million lives — and counting. The promise of the new year is that vaccines are finally here and offer a way out.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

The U.S. is now a few weeks into its massive COVID-19 vaccination campaign, and it's been going a little more slowly than federal officials had promised. Joining us now to talk about solutions for speeding it up is NPR's Pien Huang. Hey, Pien.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

Copyright 2021 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

Updated at 7:55 p.m. ET

People who are ages 75 and older or frontline essential workers should be next in line to get a COVID-19 vaccine, a federal advisory committee to the Centers for Disease Control and Prevention determined Sunday.

Those groups follow frontline health care workers and nursing home residents, who have already begun receiving the limited supplies of vaccines available.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

MICHEL MARTIN, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

An important federal advisory committee at the Centers for Disease Control and Prevention has added its vote of support for the Pfizer-BioNTech COVID-19 vaccine.

In an emergency meeting Saturday, the CDC's Advisory Committee on Immunization Practices voted to recommend the first COVID-19 vaccine for use for people 16 or older in the U.S, expressing hope that the vaccine would help curb the spread of the disease that has killed more than 295,000 people in the U.S.

In the U.S., front-line health care workers are likely first in line to get immunized with a COVID-19 vaccine, once the FDA says yes. But what about the rest of us?

New data released by the Department of Health and Human Services on Monday gives the most detailed picture to date of how COVID-19 is stressing individual hospitals in the United States.

The information provides nationwide data on hospital capacity and bed use at a hospital-by-hospital level. This is the first time the federal agency has released the COVID-19 hospital data it collects at the facility level. Previously, HHS released data aggregated at the state level only.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

MARY LOUISE KELLY, HOST:

Updated 5:48 p.m. ET

A federal advisory committee to the Centers for Disease Control and Prevention voted Tuesday to recommend who should get COVID-19 vaccines first once one is authorized for use.

Health care workers are expected to be first in line to be offered a COVID-19 vaccine when one is available.

It makes sense: Getting a safe, effective vaccine would help keep them and their patients healthy. Seeing doctors, nurses and medical aides getting COVID-19 vaccines would also set an example for the community.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST:

Copyright 2020 NPR. To see more, visit https://www.npr.org.

AILSA CHANG, HOST:

Top officials from Operation Warp Speed, the government's program to fast-track the development and delivery of COVID-19 vaccines, announced they've allocated 6.4 million doses of COVID-19 vaccines to states based on their total populations.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

STEVE INSKEEP, HOST:

A top U.S. Army general who is co-leading the federal COVID-19 vaccine initiative anticipates that the first of millions of Americans could start receiving COVID-19 vaccines as soon as next month.

Pages